Medical management of thyroid dysfunction in pregnancy and the postpartum

Expert Opinion on Pharmacotherapy

Volumn 9, Issue 13, 2008, Pages 2281-2293

  Okosieme, Onyebuchi E ^a   Marx, Helen ^b   Lazarus, John H ^c  

^a PRINCE CHARLES HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Hyperthyroidism; Hypothyroidism; Postpartum thyroiditis; Pregnancy

Indexed keywords

CARBIMAZOLE; CD59 ANTIGEN; CHORIONIC GONADOTROPIN; DECAY ACCELERATING FACTOR; GAMMA INTERFERON; IODINE; LEVOTHYROXINE; LIOTHYRONINE; MEMBRANE COFACTOR PROTEIN; PROPRANOLOL; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIAMAZOLE; THIONAMIDE DERIVATIVE; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ANEMIA; BONE TURNOVER; BRAIN DAMAGE; CONGENITAL MALFORMATION; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MEGADOSE; DRUG SAFETY; ESOPHAGUS ATRESIA; EUTHYROIDISM; FETUS DISEASE; FETUS OUTCOME; GOITER; HEART RATE; HUMAN; HUMORAL IMMUNITY; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNE RESPONSE; IMMUNOMODULATION; INNATE IMMUNITY; INTRAUTERINE GROWTH RETARDATION; IODINE DEFICIENCY; LACTATION; LOADING DRUG DOSE; LONG TERM CARE; LOW BIRTH WEIGHT; LOW DRUG DOSE; PATHOGENESIS; PATIENT COMPLIANCE; PLACENTAL TRANSFER; POSTPARTUM HEMORRHAGE; POSTPARTUM THYROIDITIS; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; PUERPERIUM; RECOMMENDED DRUG DOSE; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; SKIN APLASIA; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; TERATOGENICITY; THYROID DISEASE; THYROID FUNCTION; THYROIDITIS; THYROTOXICOSIS;

ANTITHYROID AGENTS; BREAST FEEDING; FEMALE; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PUERPERAL DISORDERS; THYROID GLAND; THYROID HORMONES;

EID: 52249101144     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.9.13.2281     Document Type: Review

References (109)

1. Lazarus JH, Kokandi A. Thyroid disease in relation to pregnancy: a decade of change. Clin Endocrinol (Oxf) 2000;53:265-278
2. Glinoer D. Management of hypo- and hyperthyroidism during pregnancy. Growth Horm IGF Res 2003;13(Suppl A):S45-54
3. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 1997;18:404-33
4. Brent GA. Maternal thyroid function: interpretation of thyroid function tests in pregnancy. Clin Obstet Gynecol 1997;40:3-15
5. Abalovich M, Amino N, Barbour LA, et al. Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2007;92(8 Suppl):S1-47
6. Man EB, Reid WA, Hellegers AE, Jones WS. Thyroid function in human pregnancy. III. Serum thyroxine-binding prealbumin (TBPA) and thyroxine-binding globulin (TBG) of pregnant women aged 14 through 43 years. Am J Obstet Gynecol 1969;103:338-47
7. Yoshikawa N, Nishikawa M, Horimoto M, et al. Thyroid-stimulating activity in sera of normal pregnant women. J Clin Endocrinol Metab 1989;69:891-5
8. Smyth PP, Hetherton AM, Smith DF, et al. Maternal iodine status and thyroid volume during pregnancy: correlation with neonatal iodine intake. J Clin Endocrinol Metab 1997;82:2840-3
9. Liberman CS, Pion SC, Fang SL, et al. Circulating iodide concentrations during and after pregnancy. J Clin Endocrinol Metab 1998;83:3545-9
10. Untoro J, Mangasaryan N, de Benoist B, Darnton-Hill I. Reaching optimal iodine nutrition in pregnant and lactating women and young children: programmatic recommendations. Public Health Nutr 2007;10:1527-9
11. Baloch Z, Carayon P, Conte-Devolx B, et al. Guidelines Committee, National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003;13:3-126
12. Dashe JS, Casey BM, Wells CE, et al. Thyroid-stimulating hormone in singleton and twin pregnancy: importance of gestational age-specific reference ranges. Obstet Gynecol 2005;106:753-7
13. Weetman AP. The immunology of pregnancy. Thyroid 1999;9:643-6
14. Weinberg ED. Pregnancy-associated depression of cell-mediated immunity. Rev Infect Dis 1984;6:814-31
15. Sacks G, Sargent I, Redman C. An innate view of human pregnancy. Immunol Today 1999;20:114-8
16. Saito S, Umekage H, Sakamoto Y, et al. Increased T-helper-1-type immunity and decreased T-helper-2-type immunity in patients with preeclampsia. Am J Reprod Immunol 1999;41:297-306
17. Elenkov IJ, Wilder RL, Bakalov VK, et al. IL,12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab 2001;86:4933-8
18. Kincade PW, Medina KL, Payne KJ, et al. Early B-lymphocyte precursors and their regulation by sex steroids. Immunol Rev 2000;175:128-37
19. Buyon JP. The effects of pregnancy on autoimmune diseases. J Leukoc Biol 1998;63:281-7
20. Glinoer D. Thyroid hyperfunction during pregnancy. Thyroid 1998;8:859-64
21. Marx H, Amin P, Lazarus JH. Hyperthyroidism and pregnancy. BMJ 2008;336(7645):663-7
22. Goodwin TM, Montoro M, Mestman JH, et al. The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab 1992;75:1333-7
23. Tsuruta E, Tada H, Tamaki H, et al. Pathogenic role of asialo, human chorionic gonadotropin in gestational thyrotoxicosis. J Clin Endocrinol Metab 1995;80:350-5
24. Rodien P, Brémont C, Sanson ML, et al. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med 1998;339:1823-6
25. Mestman JH. Hyperthyroidism in pregnancy. Best Pract Res Clin Endocrinol Metab 2004;18:267-88
26. Millar LK, Wing DA, Leung AS, et al. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 1994;84:946-9
27. Phoojaroenchanachai M, Sriussadaporn S, Peerapatdit T, et al. Effect of maternal hyperthyroidism during late pregnancy on the risk of neonatal low birth weight. Clin Endocrinol (Oxf) 2001;54:365-70
28. Davis LE, Lucas MJ, Hankins GD, et al. Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 1989;160:63-70
29. Easterling TR, Schmucker BC, Carlson KL, et al. Maternal hemodynamics in pregnancies complicated by hyperthyroidism. Obstet Gynecol 1991;78:348-52
30. Zimmerman D. Fetal and neonatal hyperthyroidism. Thyroid 1999;9:727-3331
31. Polak M, Le Gac I, Vuillard E, et al. Fecal and neonatal thyroid function in relation to maternal Graves' disease. Best Pract Res Clin Endocrinol Metab 2004;18:289-302
32. Momotani N, Noh J, Oyanagi H, et al. Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status. N Engl J Med 1986;315:24-8
33. Momotani N, Noh JY, Ishikawa N, Ito K. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. J Clin Endocrinol Metab 1997;82:3633-6
34. Lee YS, Loke KY, Ng SC, Joseph R. Maternal thyrotoxicosis causing central hypothyroidism in infants. J Paediatr Child Health 2002;38:206-8
35. McKenzie JM, Zakarija M. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid 1992;2:155-9
36. Laurberg P, Nygaard B, Glinoer D, et al. Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association. Eur J Endocrinol 1998;139:584-6
37. Gorman CA. Radioiodine and pregnancy. Thyroid 1999;9:721-6
38. Cooper DS. Antithyroid drugs. N Engl J Med 2005;352:905-17
39. Marchant B, Brownlie BE, Hart DM, et al. The placental transfer of propylthiouracil, methimazole and carbimazole. J Clin Endocrinol Metab 1977;45:1187-93
40. Mortimer RH, Cannell GR, Addison RS, et al. Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J Clin Endocrinol Merab 1997;82:3099-102
41. Sitar DS, Abu-Bakare A, Gardiner RJ. Propylthiouracil disposition in pregnant and post-partum women. Pharmacology 1982;25:57-60
42. Skellern GG, Knight BI, Otter M, et al. The pharmacokinetics of methimazole in pregnant patients after oral administration of carbimazole. Br J Clin Pharmacol 1980;9:145-7
43. Gardner DF, Cruikshank DP, Hays PM, Cooper DS. Pharmacology of propylthiouracil (PTU) in pregnant hyperthyroid women: correlation of maternal PTU concentrations with cord serum thyroid function tests. J Clin Endocrinol Metab 1986;62:217-20
44. Johnsson E, Larsson G, Ljunggren M. Severe malformations in infant born to hyperthyroid woman on methimazole. Lancet 1997;350:1520
45. Karlsson FA, Axelsson O, Melhus H. Severe embryopathy and exposure to methimazole in early pregnancy. J Clin Endocrinol Metab 2002;87:947-9
46. Di Gianantonio E, Schaefer C, Mastroiacovo PP, et al. Adverse effects of prenatal methimazole exposure. Teratology 2001;64:262-6
47. Momotani N, Ito K, Hamada N, et al. Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol (Oxf) 1984;20:695-700
48. Eisenstein Z, Weiss M, Katz Y, Bank H. Intellectual capacity of subjects exposed to methimazole or propylthiouracil in utero. Eur J Pediatr 1992;151:558-9
49. Messer PM, Hauffa BP, Olbricht T, et al. Antithyroid drug treatment of Graves'disease in pregnancy: long-term effects on somatic growth, intellectual development and thyroid function of the offspring. Acta Endocrinol (Copenhagen, Denmark) 1990;123:311-6
50. Azizi F, Khamseh ME, Bahreynian M, Hedayati M. Thyroid function and intellectual development of children of mothers taking methimazole during pregnancy. J Endocrinol Invest 2002;25:586-9
51. Mandel SJ, Cooper DS. The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab 2001;86:2354-9
52. Kampmann JP, Johansen K, Hansen JM, Helweg J. Propylthiouracil in human milk. Revision of a dogma. Lancet 1980;1:736-7
53. Johansen K, Andersen AN, Kampmann JP, et al. Excretion of methimazole in human milk. Eur J Clin Pharmacol 1982;23:339-41
54. Cooper DS, Bode HH, Nath B, et al. Methimazole pharmacology in man: studies using a newly developed radioimmunoassay for methimazole. J Clin Endocrinol Metab 1984;58:473-9
55. Azizi F, Khoshniat M, Bahrainian M, Hedayati M. Thyroid function and intellectual development of infants nursed by mothers taking methimazole. J Clin Endocrinol Metab 2000;85:3233-8
56. Momotani N, Yamashita R, Makino F, et al. Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil. Clin Endocrinol (Oxf) 2000;53:177-81
57. Lamberg BA, Ikonen E, Osterlund K, et al. Antithyroid treatment of maternal hyperthyroidism during lactation. Clin Endocrinol (Oxf) 1984;2:81-7
58. Klein RZ, Haddow JE, Faix J D, et al. Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol (Oxf) 1991;35:41-6
59. Mandel SJ. Hypothyroidism and chronic autoimmune thyroiditis in the pregnant state: maternal aspects. Best Pract Res Clin Endocrinol Metab 2004;18:213-24
60. Davis LE, Leveno KJ, Cunningham FG. Hypothyroidism complicating pregnancy. Obstet Gynecol 1988;72:108-12
61. Leung AS, Millar LK, Koonings PP, et al. Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol 1993;81:349-53
62. Idris I, Srinivasan R, Simm A, Page RC. Maternal hypothyroidism in early and late gestation: effects on neonatal and obstetric outcome. Clin Endocrinol (Oxf) 2005;63:560-5
63. Casey BM, Dashe JS, Wells CE, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 2005;105:239-45
64. Stagnaro-Green A, Chen X, Bogden JD, et al. The thyroid and pregnancy: a novel risk factor for very preterm delivery. Thyroid 2005;15:351-7
65. Iijima T, Tada H, Hidaka Y, et al. Effects of autoantibodies on the course of pregnancy and fetal growth. Obstet Gynecol 1997;90:364-9
66. Dendrinos S, Papasteriades C, Tarassi K, et al. Thyroid autoimmunity in patients with recurrent spontaneous miscarriages. Gynecol Endocrinol 2000;14:270-4
67. Abalovich M, Gutierrez S, Alcaraz G, et al. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 2002;12:63-8
68. Negro R, Formoso G, Mangieri T et al. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 2006;91:2587-91
69. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999;19;341:549-55
70. Pop VJ, Brouwers EP, Vider HL, et al. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol (Oxf) 2003;59:282-8
71. Pop VJ, de Vries E, van Baar AL, et al. Maternal thyroid peroxidase antibodies during pregnancy: a marker of impaired child development? J Clin Endocrinol Metab 1995;80:3561-6
72. Casey BM, Dashe JS, Spong CY, et al. Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy. Obstet Gynecol 2007;109:1129-35
73. Mandel SJ, Brent GA, Larsen PR. Levothyroxine therapy in patients with thyroid disease. Ann Intern Med 1993;119:492-502
74. Bell GM, Sawers JS, Forfar JC, et al. The effect of minor increments in plasma thyroxine on heart rate and urinary sodium excretion. Clin Endocrinol (Oxf) 1983;18:511-6
75. Harvey RD, McHardy KC, Reid IW, et al. Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers. J Clin Endocrinol Metab 1991;72:1189-94
76. Greenspan SL, Greenspan FS. The effect of thyroid hormone on skeletal integrity. Ann Intern Med 1999;130:750-8
77. Alexander EK, Marqusee E, Lawrence J, et al. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 2004;351:241-9
78. Mandel SJ, Larsen PR, Seely EW, Brent GA. Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med 1990;12;323:91-96
79. Roti E, Fang SL, Green K, et al. Human placenta is an active site of thyroxine and 3,3′5-triiodothyronine tyrosyl ring deiodination. J Clin Endocrinol Metab 1981;53:498-501
80. Lazarus JH. Thyroid disorders associated with pregnancy: etiology, diagnosis, and management. Treat Endocrinol 2005;4:31-41
81. Muller AF, Drexhage HA, Berghout A. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev 2001;22:605-30
82. Stagnaro-Green A. Postpartum thyroiditis. Best Pract Res Clin Endocrinol Metab 2004;18:303-16
83. Roberton HEW. Lassitude, coldness, and hair changes following pregnancy, and their response to treatment with thyroid extract. BMJ 1948;2:2275-6
84. Amino N, Miyai K, Onishi T, et al. Transient hypothyroidism after delivery in autoimmune thyroiditis. J Clin Endocrinol Metab 1976;42:296-301
85. Ginsberg J, Walfish PG. Postpartum transient thyrotoxicosis with painless thyroiditis. Lancet 1977;1:1125-8
86. Nicholson WK, Robinson KA, Smallridge RG et al. Prevalence of postpartum thyroid dysfunction: a quantitative review. Thyroid 2006;16:573-82
87. Fung HYM, Kologlu M, Collison K, et al. Postpartum thyroid dysfunction in Mid-Glamorgan. BMJ 1988;296:241-4
88. Lazarus JH, Hall R, Othman S, et al. The clinical spectrum of postpartum thyroid disease. QJM 1996;89:429-35
89. Premawardhana LDKE, Parkes AB, Ammari F, et al. Postpartum thyroiditis and long-term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity. J Clin Endocrinol Metab 2000;85:71-5
90. Harris B, Fung H, Johns S, et al. Transient post-partum thyroid dysfunction and postnatal depression. J Affect Disord 1989;17:243-9
91. Harris B, Othman S, Davies JA, et al. Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BMJ 1992;305:152-6
92. Pop VJ, de Rooy HA, Vader HL, et al. Postpartum thyroid dysfunction and depression in an unselected population. N Engl J Med 1991;324:1815-6
93. Kent GN, Stuckey BG, Allen JR, et al. Postpartum thyroid dysfunction: clinical assessment and relationship to psychiatric affective morbidity. Clin Endocrinol (Oxf) 1999;51:429-38
94. Stagnaro-Green A, Roman SH, Cobin RH, et al. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 1990;264:1422-5
95. Glinoer D, Soto MF, Bourdoux P, et al. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. J Clin Endocrinol Metab 1991;73:421-7
96. Muller AF, Verhoeff A, Mantel MJ, Berghout A. Thyroid autoimmunity and abortion: a prospective study in women undergoing in vitro fertilization. Ferril Steril 1999;71:30-4
97. Amino N, Tada H, Hidaka Y. Postpartum autoimmune thyroid syndrome: a model of aggravation of autoinumme disease. Thyroid 1999;9:705-13
98. Jansson R, Totterman TH, Sallstrom J, Dahlberg PA. Intrathyroidal and circulating lymphocyte subsets in different stages of autoimmune postpartum thyroiditis. J Clin Endocrinol Metab 1984;58:942-6
99. Mizukami Y, Michigishi T, Nonomura A, et al. Postpartum thyroiditis. A clinical, histologic, and immunopathologic study of 15 cases. Am J Clin Pathol 1993;100:200-5
100. Kologlu M, Fung H, Darke C, et al. Postpartum thyroid dysfunction and HLA status. Eur J Clin Invest 1990;20:56-60
101. Othman S, Phillips DI, Lazarus JH, et al. Iodine metabolism in postpartum thyroiditis. Thyroid 1992;2:107-111
102. Parkes AB, Black EG, Adams H, et al. Serum thyroglobulin: an early indicator of autoimmune post-partum thyroiditis. Clin Endocrinol (Oxf) 1994;41:9-14
103. Parkes AB, Othman S, Hall R, et al. The role of complement in the pathogenesis of postpartum thyroiditis. J Clin Endocrinol Metab 1994;79:395-400
104. Parkes AB, Ochman S, Hall R, et al. The role of complement in the pathogenesis of postpartum thyroiditis: relationship between complement activation and disease presentation and progression. Eur J Endocrinol 1995;133:210-5
105. Okosieme OE, Parkes AB, McCullough B, et al. Complement activation in postpartum thyroiditis. QJM 2002;95:173-9
106. Jansson R, Bernander S, Karlsson A, et al. Autoimmune thyroid dysfunction in the postpartum period. J Clin Endocrinol Metab 1984;58:681-7
107. Lazarus JH, Premawardhana LD. Screening for thyroid disease in pregnancy. J Clin Pathol 2005;58:449-52
108. Negro R, Greco G, Mangieri T, et al. The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab 2007;92:1263-8
109. Vaidya B, Anthony S, Bilous M, et al. Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high-risk case finding? J Clin Endocrinol Metab 2007;92:203-7